Live feed
Filing
SC 13G/A
SC 13G/A0001393825-19-000009·Armata Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
AMPLIPHI BIOSCIENCES CORP
Security class unavailable · CUSIP: 03211P301
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 498,890
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001393825-19-000009
- Form type
- SC 13G/A
- Filer
- Armata Pharmaceuticals, Inc.
- CIK
- CIK 921114
- Filed
- Jan 30, 2019
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership